The Significance of Soluble Interleukin-2 Receptor in Monitoring Disease Relapse in Patients with Nasopharyngeal Cancer

Japanese Journal of Clinical Oncology

Volumn 28, Issue 12, 1998, Pages 729-732

  Wu, Le Jung ^a,b   Chen, Kuang Y ^a,b   Chi, Kwan Hwa ^a,b   Chen, Sen Yu ^a,b   Liang, Mien Jung ^a,b   Shiau, Chen Ying ^a,b   Wang, Ling Wei ^a,b   Liu, Yu Ming ^a,b   Chow, Kuan Chih ^a   Yen, Sang Hue ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

ELISA; Locoregional recurrence; Metastasis; Nasopharyngeal cancer; SIL 2R

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; METASTASIS; NASOPHARYNX TUMOR; PATHOLOGY; T LYMPHOCYTE; TUMOR RECURRENCE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0032245777     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.12.729     Document Type: Article

References (18)

1. Hamblin AS. Cytokines and Cytokine Receptors. 2nd edition. Oxford Oxford University Press, 1993;24-5.
2. Rubin LA, Jay G, Nelson DL The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol 1986;137:3841-4.
3. Wang HM, Smith KA. The interleukin 2 receptor. Functional consequences of its biomolecular structure. J Exp Med 1987;166:1055-69.
4. Rubin LA, Nelson DL The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Int Med 1990;113:619-27.
5. Lissoni P, Bami S, Rovelli F, Viviani S, Maestroni GJ, Conti A, et al. The biological significance of soluble interleukin-2 receptors in solid tumors. Eur J Cancer 1990;26:33-6.
6. Lai KN, Ho S, Leung JC, Tsao SY. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma. Cancer 1991;67:2180-5.
7. Hsu MM, Ko JY, Chang YL. Elevated levels of soluble interleukin 2 receptor and tumor necrosis factor in nasopharyngeal carcinoma. Arch Otol - Head & Neck Surg 1991;117:1257-9.
8. Shanmugaratnam K, Chan SH, De-The G, Goh JE, Khor TH, Simons MJ, et al Histopathology of nasopharyngeal carcinoma: correlation with epidemiology, survival rates and other biological characteristics. Cancer 1979;44:1029-44.
9. Herait P, Ganem G, Lipinski M, Carlu C, Micheau C, Schwaab G, et al. Lymphcyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells. Br. J. Cancer 1987;55:135-9.
10. Lakhdar M, Ben Aribia MH, Maalej M, Ladgham A. Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: numerous CD8- and CD16-positive cells in the tumor. Int J Cancer 1991;48:57-61.
11. Ferradini L, Miescher S, Stoeck M, Busson P, Barras C, Cerf-Bensussan N, et al. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma. Int J Cancer 1991;47:362-70
12. Liebowitz D, Kieff E, Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, editors. The Human Herpes Viruses. New York: Raven Press, 1993, 107-72.
13. Wolf H, Hansen H zur, Becker V. EB-viral genomes in epithelial nasopharyngeal carcinoma cells. Nature-New Biol 1973;244:245-7
14. Hausen H zur, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, et al EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970;228:1056-8
15. + cells in the blood of nasopharyngeal carcinoma patients. Cancer Immunol Immunother 1993;37:131-9.
16. Lakhdar M, Ellouz R, Kammoun H, Ben H, Tira S, Khedhin N, et al. Presence of in vivo-activated T-cells expressing HLA-DR molecules and IL-2 receptors in peripheral blood of patients with nasopharyngeal carcinoma. Int J Cancer 1987;39:663-9
17. McMillan DN, Kernohan NM, Flett ME, Heys SD, Deehan DJ, Sewell HF, et al. Interleukin-2 receptor expression and interleukin 2 localization in human solid tumor cells in situ and in vitro evidence for a direct role in the regulation of tumor cell proliferation. Int J Cancer 1995;60:766-72.
18. Yasumura S, Lin WC, Weidmann E, Hebda P, Whiteside TL. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2 Int J Cancer 1994;59:225-34.